Wittrup, K. Dane.
K. Dane Wittrup
VIAF ID: 249705729 (Personal)
Permalink: http://viaf.org/viaf/249705729
Preferred Forms
- 100 0 _ ‡a K. Dane Wittrup
-
-
- 100 1 _ ‡a Wittrup, K. Dane
-
-
- 100 1 _ ‡a Wittrup, K. Dane
- 100 1 _ ‡a Wittrup, K. Dane
-
- 100 1 _ ‡a Wittrup, K. Dane
- 100 1 _ ‡a Wittrup, K. Dane
-
-
4xx's: Alternate Name Forms (6)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
A33 antigen displays persistent surface expression | |
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy | |
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR | |
Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution | |
Biochemical engineering VIII, 1994: | |
CD8+ T-cell responses rapidly select for antigen-negative tumor cells in the prostate. | |
Detection of amyloid β oligomers toward early diagnosis of Alzheimer's disease | |
Directed evolution for improved secretion of cancer-testis antigen NY-ESO-1 from yeast. | |
Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor | |
Equilibrium and dynamic design principles for binding molecules engineered for reagentless biosensors. | |
Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody | |
Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits | |
High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice | |
High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming | |
Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor | |
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses | |
Localized immunotherapy via liposome-anchored Anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity. | |
Maximizing response to intratumoral immunotherapy in mice by tuning local retention | |
A Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA. | |
Pharmacokinetic tuning of protein-antigen fusions enhances the immunogenicity of T-cell vaccines | |
Protein Engineering and Selection Using Yeast Surface Display. | |
Protein engineering for therapeutics. | |
Quantitative fundamentals of molecular and cellular bioengineering | |
Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries | |
Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticles | |
Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2. | |
Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin. | |
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates. | |
Tumor cells are dislodged into the pulmonary vein during lobectomy | |
Yeast surface display for antibody isolation: library construction, library screening, and affinity maturation. |